• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新精神活性物质对公共健康影响的最新研究进展。

An Update on the Implications of New Psychoactive Substances in Public Health.

机构信息

Centro de Investigação em Ciências da Saúde (CICS-UBI), Universidade da Beira Interior, 6200-506 Covilha, Portugal.

Laboratório de Fármaco-Toxicologia, UBIMedical, Universidade da Beira Interior, 6200-284 Covilha, Portugal.

出版信息

Int J Environ Res Public Health. 2022 Apr 17;19(8):4869. doi: 10.3390/ijerph19084869.

DOI:10.3390/ijerph19084869
PMID:35457736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9028227/
Abstract

The emergence of new psychoactive substances has earned a great deal of attention, and several reports of acute poisoning and deaths have been issued involving, for instance, synthetic opiates. In recent years, there have been profound alterations in the legislation concerning consumption, marketing, and synthesis of these compounds; rapid alert systems have also been subject to changes, and new substances and new markets, mainly through the internet, have appeared. Their effects and how they originate in consumers are still mostly unknown, primarily in what concerns chronic toxicity. This review intends to provide a detailed description of these substances from the point of view of consumption, toxicokinetics, and health consequences, including case reports on intoxications in order to help researchers and public health agents working daily in this area.

摘要

新精神活性物质的出现引起了广泛关注,有几起因涉及合成阿片类药物的急性中毒和死亡的报告。近年来,有关这些化合物的消费、营销和合成的立法发生了深刻变化;快速警报系统也发生了变化,新的物质和新的市场(主要通过互联网)出现了。它们的作用以及它们在消费者中的起源在很大程度上仍然未知,主要涉及慢性毒性。本综述旨在从消费、毒代动力学和健康后果的角度对这些物质进行详细描述,包括中毒案例报告,以帮助在这一领域工作的研究人员和公共卫生人员。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/a359edb51698/ijerph-19-04869-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/8b53eb64af07/ijerph-19-04869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/1096272891e4/ijerph-19-04869-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/f2251bf65227/ijerph-19-04869-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/76066b59ebc0/ijerph-19-04869-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/56287d7bcc9a/ijerph-19-04869-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/ba61cc1ebadf/ijerph-19-04869-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/acc75027e1a7/ijerph-19-04869-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/13ffa84358a1/ijerph-19-04869-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/97b49bf349b9/ijerph-19-04869-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/48a65071f071/ijerph-19-04869-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/1e5dc4c0f781/ijerph-19-04869-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/215cba036670/ijerph-19-04869-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/ba3282b78170/ijerph-19-04869-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/db345005f5b8/ijerph-19-04869-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/7dd94f41521c/ijerph-19-04869-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/e458c1427617/ijerph-19-04869-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/853e0d337084/ijerph-19-04869-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/a359edb51698/ijerph-19-04869-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/8b53eb64af07/ijerph-19-04869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/1096272891e4/ijerph-19-04869-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/f2251bf65227/ijerph-19-04869-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/76066b59ebc0/ijerph-19-04869-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/56287d7bcc9a/ijerph-19-04869-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/ba61cc1ebadf/ijerph-19-04869-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/acc75027e1a7/ijerph-19-04869-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/13ffa84358a1/ijerph-19-04869-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/97b49bf349b9/ijerph-19-04869-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/48a65071f071/ijerph-19-04869-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/1e5dc4c0f781/ijerph-19-04869-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/215cba036670/ijerph-19-04869-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/ba3282b78170/ijerph-19-04869-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/db345005f5b8/ijerph-19-04869-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/7dd94f41521c/ijerph-19-04869-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/e458c1427617/ijerph-19-04869-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/853e0d337084/ijerph-19-04869-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b7c/9028227/a359edb51698/ijerph-19-04869-g018.jpg

相似文献

1
An Update on the Implications of New Psychoactive Substances in Public Health.新精神活性物质对公共健康影响的最新研究进展。
Int J Environ Res Public Health. 2022 Apr 17;19(8):4869. doi: 10.3390/ijerph19084869.
2
New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?新型精神活性物质与消退的 COVID-19 大流行:真的要回到“正常”吗?
Acta Biomed. 2022 May 11;93(2):e2022186. doi: 10.23750/abm.v93i2.13008.
3
A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.新型精神活性物质“合法兴奋剂”对重症精神疾病患者影响的系统评价
J Psychiatr Ment Health Nurs. 2016 Jun;23(5):267-81. doi: 10.1111/jpm.12297. Epub 2016 Apr 1.
4
New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.新型精神活性物质:欧盟信息交流和创新法律应对的演变。
Int J Environ Res Public Health. 2020 Nov 23;17(22):8704. doi: 10.3390/ijerph17228704.
5
The Growing Problem of New Psychoactive Substances (NPS).新型精神活性物质(NPS)日益严重的问题。
Curr Top Behav Neurosci. 2017;32:1-18. doi: 10.1007/7854_2016_34.
6
New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics.新型精神活性物质:近期关于其毒效动力学和毒代动力学的出版物综述。
Arch Toxicol. 2016 Oct;90(10):2421-44. doi: 10.1007/s00204-016-1812-x. Epub 2016 Sep 24.
7
3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.3,4-亚甲二氧基吡咯戊酮(MDPV):一种新的在网上销售的具有滥用倾向的设计药物的化学、药理学和毒理学。
Toxicol Lett. 2012 Jan 5;208(1):12-5. doi: 10.1016/j.toxlet.2011.10.002. Epub 2011 Oct 8.
8
Current challenges and problems in the field of new psychoactive substances in Germany from a law enforcement perspective.从执法角度看德国新型精神活性物质领域当前面临的挑战与问题。
Drug Test Anal. 2014 Jul-Aug;6(7-8):876-8. doi: 10.1002/dta.1604. Epub 2014 Jan 10.
9
Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.瑞士某城市急诊科中因精神活性物质急性中毒导致的病例表现:病例系列
BMC Pharmacol Toxicol. 2016 May 26;17(1):25. doi: 10.1186/s40360-016-0068-7.
10
Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis.英国 2016 年精神药物法案对国家毒物信息服务中心报告的与新型精神活性物质相关的毒性发作的影响:一项时间序列分析。
Int J Drug Policy. 2020 Mar;77:102672. doi: 10.1016/j.drugpo.2020.102672. Epub 2020 Feb 4.

引用本文的文献

1
New psychoactive substances: a multidisciplinary review of challenges and their diverse character.新型精神活性物质:对挑战及其多样特性的多学科综述
Daru. 2025 Aug 7;33(2):29. doi: 10.1007/s40199-025-00572-z.
2
The Dark Side of "Smart Drugs": Cognitive Enhancement vs. Clinical Concerns.“聪明药”的阴暗面:认知增强与临床担忧
Toxics. 2025 Mar 26;13(4):247. doi: 10.3390/toxics13040247.
3
Sublethal Concentrations of 2C-I and 25I-NBOMe Designer Drugs Impact Development and Reproductive Behavior.2C-I和25I-NBOMe这类设计药物的亚致死浓度会影响发育和生殖行为。

本文引用的文献

1
An updated review on synthetic cathinones.合成卡西酮的最新综述。
Arch Toxicol. 2021 Sep;95(9):2895-2940. doi: 10.1007/s00204-021-03083-3. Epub 2021 Jun 8.
2
Piperazine skeleton in the structural modification of natural products: a review.哌嗪骨架在天然产物结构修饰中的应用:综述。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1165-1197. doi: 10.1080/14756366.2021.1931861.
3
R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine.与S(+)-甲氧麻黄酮相比,R(-)-甲氧麻黄酮具有快速且持续的抗抑郁作用,且行为副作用较少。
Int J Mol Sci. 2025 Mar 26;26(7):3039. doi: 10.3390/ijms26073039.
4
Synthetic Cathinones Induce Developmental Arrest, Reduce Reproductive Capacity, and Shorten Lifespan in the Model.合成卡西酮在该模型中会导致发育停滞、降低生殖能力并缩短寿命。
J Xenobiot. 2025 Feb 18;15(1):33. doi: 10.3390/jox15010033.
5
[Simultaneous determination of 51 indazole-type synthetic cannabinoids in urine and blood by online solid-phase extraction-liquid chromatography-linear ion trap mass spectrometry].[在线固相萃取-液相色谱-线性离子阱质谱法同时测定尿液和血液中的51种吲唑型合成大麻素]
Se Pu. 2025 Feb;43(2):164-176. doi: 10.3724/SP.J.1123.2024.02008.
6
Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples.临床口腔液样本中新型精神活性物质与传统滥用药物的流行病学研究。
Basic Clin Pharmacol Toxicol. 2025 Feb;136(2):e14117. doi: 10.1111/bcpt.14117.
7
From Psychoactivity to Antimicrobial Agents: Multifaceted Applications of Synthetic Cathinones and Extracts.从精神活性物质到抗菌剂:合成卡西酮及其提取物的多方面应用
Molecules. 2024 Dec 15;29(24):5918. doi: 10.3390/molecules29245918.
8
Metabolic characterization of the new benzimidazole synthetic opioids - nitazenes.新型苯并咪唑合成阿片类药物——硝氮烯的代谢特征
Front Pharmacol. 2024 Jul 18;15:1434573. doi: 10.3389/fphar.2024.1434573. eCollection 2024.
9
α-Pyrrolidinohexanophenone (α-PHP) and α-Pyrrolidinoisohexanophenone (α-PiHP): A Review.α-吡咯烷基己酮(α-PHP)和α-吡咯烷基异己酮(α-PiHP):综述
Life (Basel). 2024 Mar 22;14(4):429. doi: 10.3390/life14040429.
10
Tackling new psychoactive substances through metabolomics: UHPLC-HRMS study on natural and synthetic opioids in male and female murine models.通过代谢组学应对新型精神活性物质:UHPLC-HRMS对雄性和雌性小鼠模型中天然和合成阿片类药物的研究
Sci Rep. 2024 Apr 24;14(1):9432. doi: 10.1038/s41598-024-60045-2.
Neuropharmacology. 2021 Aug 1;193:108619. doi: 10.1016/j.neuropharm.2021.108619. Epub 2021 May 20.
4
Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples.天然来源的精神活性物质:毒理学方面、治疗特性及生物样本中的分析。
Molecules. 2021 Mar 5;26(5):1397. doi: 10.3390/molecules26051397.
5
25CN-NBOMe Metabolites in Rat Urine, Human Liver Microsomes and Structure Determination and Synthesis of the Most Abundant Metabolites.大鼠尿液、人肝微粒体中的25CN-NBOMe代谢产物以及最丰富代谢产物的结构测定与合成
Metabolites. 2021 Mar 31;11(4):212. doi: 10.3390/metabo11040212.
6
United Nations Office on Drugs and Crime: Recommended methods for the Identification and Analysis of Synthetic Cannabinoid Receptor Agonists in Seized Materials.联合国毒品和犯罪问题办公室:查获材料中合成大麻素受体激动剂的鉴定和分析推荐方法。
Forensic Sci Int Synerg. 2021 Feb 4;3:100129. doi: 10.1016/j.fsisyn.2020.11.003. eCollection 2021.
7
Identification of human cytochrome P450 isozymes involved in the oxidative metabolism of carfentanil.鉴定人细胞色素 P450 同工酶在卡芬太尼氧化代谢中的作用。
Toxicol Lett. 2021 Jun 1;343:28-33. doi: 10.1016/j.toxlet.2021.02.017. Epub 2021 Feb 27.
8
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review.新型精神活性物质(NPS)与血清素综合征发病:系统评价。
Exp Neurol. 2021 May;339:113638. doi: 10.1016/j.expneurol.2021.113638. Epub 2021 Feb 8.
9
New psychoactive substances: a review and updates.新型精神活性物质:综述与更新
Ther Adv Psychopharmacol. 2020 Dec 17;10:2045125320967197. doi: 10.1177/2045125320967197. eCollection 2020.
10
Toxicology and Analysis of Psychoactive Tryptamines.精神作用色胺类的毒理学和分析。
Int J Mol Sci. 2020 Dec 4;21(23):9279. doi: 10.3390/ijms21239279.